Cerebras Systems (NASDAQ:CBRS) CEO Andrew Feldman Sells 26,644 Shares

Cerebras Systems Inc. (NASDAQ:CBRSGet Free Report) CEO Andrew Feldman sold 26,644 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $222.22, for a total transaction of $5,920,829.68. Following the completion of the transaction, the chief executive officer directly owned 66,853 shares of the company’s stock, valued at $14,856,073.66. This represents a 28.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Cerebras Systems Trading Down 2.0%

NASDAQ:CBRS opened at $215.69 on Thursday. The firm’s 50-day simple moving average is $208.94. Cerebras Systems Inc. has a 52 week low of $160.81 and a 52 week high of $386.34.

Cerebras Systems (NASDAQ:CBRSGet Free Report) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($2.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($2.77). The firm had revenue of $209.87 million during the quarter. Cerebras Systems’s quarterly revenue was up 74.3% compared to the same quarter last year. As a group, analysts predict that Cerebras Systems Inc. will post -0.52 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cerebras Systems

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBRS. Tiger Pacific Capital LP purchased a new position in Cerebras Systems during the 2nd quarter valued at approximately $221,000. Ratan Capital Management LP purchased a new stake in shares of Cerebras Systems during the 2nd quarter worth approximately $4,641,000. Bank of New York Mellon Corp purchased a new stake in shares of Cerebras Systems during the 2nd quarter worth approximately $6,118,000. Finally, Wellington Management Group LLP bought a new position in shares of Cerebras Systems during the 2nd quarter valued at approximately $194,853,000.

Cerebras Systems News Roundup

Here are the key news stories impacting Cerebras Systems this week:

  • Positive Sentiment: Cerebras unveiled its CS-4 rack-scale AI accelerator, claiming it can deliver up to 30 times faster inference than GPU-based solutions. The company is targeting the growing market for real-time AI applications and chatbot queries. Cerebras Unveils CS-4
  • Positive Sentiment: Analysts at Rosenblatt Securities and Needham reaffirmed “buy” ratings and set $300 price targets, implying substantial upside from the recent trading level. The broader analyst consensus remains “Moderate Buy.”
  • Positive Sentiment: Trading in CBRS call options was unusually active, with investors purchasing 57,909 calls—about 42% above typical volume—indicating increased speculative interest in a possible rebound.
  • Positive Sentiment: Investor attention is also supported by Cerebras’ wafer-scale technology, reported progress with OpenAI, and partnerships involving AMD and Amazon. A large backlog and strong AI-inference demand could support future growth. Cerebras comeback hinges on new chip
  • Neutral Sentiment: The CS-4’s “30 times faster” figure is a company claim that still requires validation through customer adoption, independent benchmarks, and commercial deployments. The launch may therefore create enthusiasm without immediately changing financial results.
  • Negative Sentiment: Director Eric Vishria sold 68,268 shares for approximately $15.7 million, reducing his direct ownership by 68.5%. The transaction occurred under a pre-arranged Rule 10b5-1 plan, but its size may still weigh on sentiment. SEC insider sale filing
  • Negative Sentiment: Director Steven Vassallo separately sold 50,000 shares worth about $10.9 million, cutting his ownership by 50.2%. Two sizable insider sales in a short period can reinforce profit-taking concerns.
  • Negative Sentiment: Cerebras recently reported a $2.98-per-share loss versus the expected $0.21 loss, despite revenue growth of 74.3% to $209.9 million. The large earnings miss keeps profitability and valuation as key risks.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CBRS. Wall Street Zen upgraded Cerebras Systems from a “sell” rating to a “hold” rating in a research note on Saturday, August 15th. Zacks Research upgraded shares of Cerebras Systems to a “hold” rating in a research report on Tuesday, June 9th. Needham & Company LLC reissued a “buy” rating and issued a $300.00 target price on shares of Cerebras Systems in a report on Wednesday. Freedom Capital upgraded shares of Cerebras Systems to a “hold” rating in a research report on Monday, June 29th. Finally, Craig Hallum assumed coverage on shares of Cerebras Systems in a research note on Monday, June 8th. They set a “buy” rating and a $325.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $299.90.

View Our Latest Stock Analysis on CBRS

About Cerebras Systems

(Get Free Report)

Cerebras Systems is a technology company focused on building artificial intelligence infrastructure, including hardware and software designed to accelerate deep learning and large-scale AI workloads. The company is best known for its wafer-scale processor architecture, which is intended to provide high-performance compute for training and inference applications.

In addition to its AI chips, Cerebras offers systems and related software tools that support researchers and enterprises working with machine learning models.

See Also

Insider Buying and Selling by Quarter for Cerebras Systems (NASDAQ:CBRS)

Receive News & Ratings for Cerebras Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerebras Systems and related companies with MarketBeat.com's FREE daily email newsletter.